SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General statement of acquisition of beneficial ownership:
SEC Accession No. 0001193125-21-354079
Filing Date
2021-12-10
Accepted
2021-12-10 17:01:04
Documents
2
Group Members
JAMES E. THOMASTHOMAS, MCNERNEY & PARTNERS II, L.P.THOMAS, MCNERNEY & PARTNERS II, LLCTHOMAS, MCNERNEY & PARTNERS, L.P.TMP ASSOCIATES II, L.P.TMP ASSOCIATES, L.P.TMP NOMINEE II, LLCTMP NOMINEE, LLC

Document Format Files

Seq Description Document Type Size
1 SC 13D d245037dsc13d.htm SC 13D 162042
2 EX-99.1 d245037dex991.htm EX-99.1 11406
  Complete submission text file 0001193125-21-354079.txt   175440
Mailing Address 45 SOUTH SEVENTH STREET SUITE 3060 MINNEAPOLIS MN 55402
Business Address 45 SOUTH SEVENTH STREET SUITE 3060 MINNEAPOLIS MN 55402 (612) 465-8660
Thomas, McNerney & Partners, LLC (Filed by) CIK: 0001335196 (see all company filings)

IRS No.: 943393928 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D

Mailing Address 555 SKOKIE BOULEVARD, SUITE 340 NORTHBROOK IL 60062
Business Address 555 SKOKIE BOULEVARD, SUITE 340 NORTHBROOK IL 60062 (847) 562-4300
Clarus Therapeutics Holdings, Inc. (Subject) CIK: 0001817944 (see all company filings)

IRS No.: 851231852 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-91924 | Film No.: 211486083
SIC: 2836 Biological Products, (No Diagnostic Substances)